The present invention provides a compound of Formula I or Formula II: ##STR00001## enantiomer, diastereomer, prodrug, solvate, metabolite, or pharmaceutically acceptable salt thereof, wherein constituent variables are provided herein. The compounds of Formula I and II are modulators of metalloproteases and are useful in treating diseases associated with metalloprotease activity such as arthritis, cancer, cardiovascular disorders, skin disorders, inflammation and allergic conditions.

 
Web www.patentalert.com

< Novel Pyrimidine-2,4-Diamine Derivatives and their Use as Modulators of Small-Conductance Calcium-Activated Potassium Channels

> Corticotropin releasing factor 2 receptor agonists

> Heterocyclic Oxime Compounds a Process for Their Preparation and Pharmaceutical Compositions Containing Them

~ 00517